Survival depending of ischemic or idiopathic dilated cardiomyopathy in patient implanted with a left ventricular assist device in destination therapy or bridge to transplantation.

27 August 2016 (00:00 - 00:00)

Organised by:

Sign in to view the resources

About the speaker

Doctor Vincent Galand

Hospital Pontchaillou of Rennes, Rennes (France)

19 More presentations in this session

Presentation thumbnail

Transpulmonary vs. right heart thermodilution measurements of cardiac output during percutaneous mechanical cardiac support with the impella device - implications for therapeutic decision making

Doctor P. Doeblin (Berlin, DE)

Abstract Slides

Presentation thumbnail

Transcriptional evaluation of Relaxin and Endothelin-1 axis in heart failure patients: first evidence of its involvement during left ventricular assist device support

Doctor M. Cabiati (Pisa, IT)

Presentation thumbnail

Time course of the modified endstage liver disease score and oxidative stress early after left ventricular assist device implant for end stage heart failure

Doctor L. Botta (Bologna, IT)

Presentation thumbnail

Comparison of outcomes and complications between percutaneous versus surgical access for emergency implantation of extracorporeal membrane oxygenation (ECMO)

Doctor C. Saint Etienne (Tours, FR)

Abstract Slides

Presentation thumbnail

Is lactate clearance a predictor for survival in patients with extracorporeal life support?

Doctor S. Haberkorn (Duesseldorf, DE)

Abstract Slides

Access the full session

Session thumbnail

Poster session 2 - Assist devices and more

The Event

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources